Beyond Air Inc. (XAIR)
NASDAQ: XAIR
· Real-Time Price · USD
2.54
-0.77 (-23.26%)
At close: Sep 09, 2025, 3:59 PM
2.56
0.76%
After-hours: Sep 09, 2025, 07:59 PM EDT
-23.26% (1D)
| Bid | 2.54 |
| Market Cap | 13.27M |
| Revenue (ttm) | 4.78M |
| Net Income (ttm) | -42.12M |
| EPS (ttm) | -10.01 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -0.57 |
| Analyst | Buy |
| Ask | 2.63 |
| Volume | 3,184,703 |
| Avg. Volume (20D) | 3,004,546 |
| Open | 2.97 |
| Previous Close | 3.31 |
| Day's Range | 2.52 - 3.00 |
| 52-Week Range | 2.02 - 13.52 |
| Beta | 0.28 |
About XAIR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XAIR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XAIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Beyond Air Inc. is scheduled to release its earnings on
Nov 10, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
21 hours ago
Beyond Air shares are trading lower. The company r...
Unlock content with
Pro Subscription
2 days ago
+49.77%
NeuroNOS shares are trading higher after the company announced the FDA granted Orphan Drug Designation to BA-101 for the treatment of Glioblastoma.
3 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New Investment in Beyond Air, Inc. (NASDAQ:XAIR)Squarepoint Ops LLC acquired a new position in shares of Beyond Air, Inc. (NASDAQ:XAIR – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional ...